Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019
- 1 July 2020
- journal article
- editorial
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (1), 22-28
- https://doi.org/10.1164/rccm.202003-0576up
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- FHIT, a Novel Modifier Gene in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research StatementAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Under Pressure to Clarify Pulmonary Hypertension Clinical RiskAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Mild Elevation of Pulmonary Arterial Pressure as a Predictor of MortalityAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Redefining pulmonary hypertensionThe Lancet Respiratory Medicine, 2017
- Gut–Lung Connection in Pulmonary Arterial HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2017
- Translational Advances in the Field of Pulmonary Hypertension.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling HubsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseThe New England Journal of Medicine, 2017
- Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertensionNature Medicine, 2015
- Inhibition of VEGF receptors causes lung cell apoptosis and emphysemaJCI Insight, 2000